Article
Neuronal and tumourigenic boundaries of glioblastoma plasticity
29 Nov 2022
Abstract excerpt
Glioblastoma (GBM) remains the most lethal primary brain cancer largely due to recurrence of treatment-resistant disease. Current therapies are ultimately ineffective as GBM tumour cells adapt their identity to escape treatment. Recent advances in single-cell epigenetics and transcriptomics highlight heterogeneous cell populations in GBM tumours originating from unique cancerous genetic aberrations. However, they...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
